Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02590107 · ClinicalTrials.gov registry record · NA
Early Oral Supplementation in Improving Nutritional Status in Patients Undergoing Hematopoietic Stem Cell Transplant
A NA study, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT02590107 is a NA study that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 5 participants.
The verdict
NCT02590107, a NA study, was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This clinical trial studies the use of early oral supplementation in improving nutritional status in participants undergoing hematopoietic stem cell transplant. Impaired nutritional status in participants undergoing hematopoietic stem cell transplant has been linked to decreased outcomes such as increased length of hospital stay and increased time to engraftment (an important milestone in transplant recovery). Early oral supplementation may increase nutritional status and help to promote a positive outcome in participants undergoing transplant.
Interventions
- DIETARY_SUPPLEMENT Boost Plus
- DIETARY_SUPPLEMENT Pro-Stat 101
- DIETARY_SUPPLEMENT Milkshake
- OTHER daily food diaries
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2016-04-01 |
| Est. Completion | 2018-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02590107
The ClinicalTrials.gov registry entry for NCT02590107 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Boost Plus is the first listed.
NCT02590107 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02590107 about?
NCT02590107 is a clinical study titled "Early Oral Supplementation in Improving Nutritional Status in Patients Undergoing Hematopoietic Stem Cell Transplant". This clinical trial studies the use of early oral supplementation in improving nutritional status in participants undergoing hematopoietic stem cell transplant. Impaired nutritional status in participants undergoing hematopoietic stem cell transplant has been linked to decreased outcomes such as inc...
What is the current status of trial NCT02590107?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2016-04-01. Estimated completion is 2018-03-01.
What interventions are being tested in trial NCT02590107?
The interventions under investigation include: Boost Plus (DIETARY_SUPPLEMENT), Pro-Stat 101 (DIETARY_SUPPLEMENT), Milkshake (DIETARY_SUPPLEMENT), daily food diaries (OTHER).
Who is sponsoring clinical trial NCT02590107?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.